Corinna Bang

Corinna Bang

Auto-generated profile, based on publicly available information

Corinna Bang

Institute of Clinical Molecular Biology University Hospital Schleswig Holstein Kiel Germany

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Cell Host & Microbe
Verified
Journal Article
Closed access
LTLouise B. Thingholm
Louise B. Thingholm
MRMalte Christoph Rühlemann
Malte Christoph Rühlemann
MKManja Koch
Manja Koch
BFBrie Fuqua
Brie Fuqua
GLGuido Laucke
Guido Laucke
CHCurtis Huttenhower
Curtis Huttenhower

1 January 2018 in Trends in Microbiology
Verified
Journal Article
Closed access
CMChristine Moissl-Eichinger
Christine Moissl-Eichinger
MPManuela Pausan
Manuela Pausan
JTJulian Taffner
Julian Taffner
GBGabriele Berg
Gabriele Berg
CBCorinna Bang
Corinna Bang
RSRuth A. Schmitz
Ruth A. Schmitz

1 April 2018 in Zoology
Verified
Journal Article
Open access
CBCorinna Bang
Corinna Bang
TDTal Dagan
Tal Dagan
PDPeter Deines
Peter Deines
NDNicole Dubilier
Nicole Dubilier
WDWolfgang J. Duschl
Wolfgang J. Duschl
TBThomas Bosch
Thomas Bosch
From protists to humans, all animals and plants are inhabited by microbial organisms. There is an increasing appreciation that these resident microbes influence the fitness of their plant and animal hosts, ultimately forming a metaorganism consisting of a uni- or multicellular host and a community of associated microorganisms. Research on host-microbe interactions has become an emerging cross-disciplinary field. In both vertebrates and invertebrates a complex microbiome confers immunological, metabolic and behavioural benefits; conversely, its disturbance can contribute to the development of disease states. However, the molecular and cellular mechanisms controlling the interactions within a metaorganism are poorly understood and many key interactions between the associated organisms remain unknown. In this perspective article, we outline some of the issues in interspecies interactions and in particular address the question of how metaorganisms react and adapt to inputs from extreme environments such as deserts, the intertidal zone, oligothrophic seas, and hydrothermal vents.

29 December 2017 in mBio
Verified
Journal Article
Open access
PDF file
KKKaisa Koskinen
Kaisa Koskinen
MPManuela R. Pausan
Manuela R. Pausan
APAlexandra K. Perras
Alexandra K. Perras
MBMichael Beck
Michael Beck
CBCorinna Bang
Corinna Bang
CMChristine Moissl-Eichinger
Christine Moissl-Eichinger
Human-associated archaea remain understudied in the field of microbiome research, although in particular methanogenic archaea were found to be regular commensals of the human gut, where they represent keystone species in metabolic processes. Knowledge on the abundance and diversity of human-associated archaea is extremely limited, and little is known about their function(s), their overall role in human health, or their association with parts of the human body other than the gastrointestinal tract and oral cavity. Currently, methodological issues impede the full assessment of the human archaeome, as bacteria-targeting protocols are unsuitable for characterization of the full spectrum of Archaea . The goal of this study was to establish conservative protocols based on specifically archaea-targeting, PCR-based methods to retrieve first insights into the archaeomes of the human gastrointestinal tract, lung, nose, and skin. Detection of Archaea was highly dependent on primer selection and the sequence processing pipeline used. Our results enabled us to retrieve a novel picture of the human archaeome, as we found for the first time Methanobacterium and Woesearchaeota (DPANN superphylum) to be associated with the human gastrointestinal tract and the human lung, respectively. Similar to bacteria, human-associated archaeal communities were found to group biogeographically, forming (i) the thaumarchaeal skin landscape, (ii) the (methano)euryarchaeal gastrointestinal tract, (iii) a mixed skin-gastrointestinal tract landscape for the nose, and (iv) a woesearchaeal lung landscape. On the basis of the protocols we used, we were able to detect unexpectedly high diversity of archaea associated with different body parts. IMPORTANCE In summary, our study highlights the importance of the primers and data processing pipeline used to study the human archaeome. We were able to establish protocols that revealed the presence of previously undetected Archaea in all of the tissue samples investigated and to detect biogeographic patterns of the human archaeome in the gastrointestinal tract and on the skin and for the first time in the respiratory tract, i.e., the nose and lungs. Our results are a solid basis for further investigation of the human archaeome and, in the long term, discovery of the potential role of archaea in human health and disease.

10 December 2021 in Journal of Hepatology
Verified
Journal Article
Closed access
MDMünevver Demir
Münevver Demir
SLSonja Lang
Sonja Lang
PHPhillipp Hartmann
Phillipp Hartmann
YDYi Duan
Yi Duan
AMAnna Martin
Anna Martin
BSBernd Schnabl
Bernd Schnabl

9 November 2020 in Gut
Verified
Journal Article
Open access
PDF file
FFFabian Frost
Fabian Frost
TKTim Kacprowski
Tim Kacprowski
MRMalte Christoph Rühlemann
Malte Christoph Rühlemann
MPMaik Pietzner
Maik Pietzner
CBCorinna Bang
Corinna Bang
MLMarkus M Lerch
Markus M Lerch
Objective: The intestinal microbiome affects the prevalence and pathophysiology of a variety of diseases ranging from inflammation to cancer. A reduced taxonomic or functional diversity of the microbiome was often observed in association with poorer health outcomes or disease in general. Conversely, factors or manifest diseases that determine the long-term stability or instability of the microbiome are largely unknown. We aimed to identify disease-relevant phenotypes associated with faecal microbiota (in-)stability. Design: A total of 2564 paired faecal samples from 1282 participants of the population-based Study of Health in Pomerania (SHIP) were collected at a 5-year (median) interval and microbiota profiles determined by 16S rRNA gene sequencing. The changes in faecal microbiota over time were associated with highly standardised and comprehensive phenotypic data to determine factors related to microbiota (in-)stability. Results: The overall microbiome landscape remained remarkably stable over time. The greatest microbiome instability was associated with factors contributing to metabolic syndrome such as fatty liver disease and diabetes mellitus. These, in turn, were associated with an increase in facultative pathogens such as Enterobacteriaceae or Escherichia/Shigella. Greatest stability of the microbiome was determined by higher initial alpha diversity, female sex, high household income and preserved exocrine pancreatic function. Participants who newly developed fatty liver disease or diabetes during the 5-year follow-up already displayed significant microbiota changes at study entry when the diseases were absent. Conclusion: This study identifies distinct components of metabolic liver disease to be associated with instability of the intestinal microbiome, increased abundance of facultative pathogens and thus greater susceptibility toward dysbiosis-associated diseases.